| Course | NR 607 Diagnosis & Management in Psychiatric-Mental Health III Practicum |
|---|---|
| Week | 6 |
| Paper type | Transition of care summary |
| Length | About 860 words, 4 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN, Psychiatric-Mental Health Nurse Practitioner (PMHNP) |
| Updated | October 2026 |
Free sample paper for NR 607 Week 6
Transition of Care Summary: K.A. Moving From the Outpatient Clinic to an Assertive Community Treatment Team, With What Happens First, the Regimen as Taken and Open Items With Owners
Student Name
College of Nursing, Chamberlain University
NR 607: Diagnosis & Management in Psychiatric-Mental Health III Practicum
Instructor Name
Month Day, Year
Transition of Care Summary: K.A. Moving From the Outpatient Clinic to an Assertive Community Treatment Team, With What Happens First, the Regimen as Taken and Open Items With Owners
What Happens First
K.A., 27, schizophrenia, transfers on 1 December 2026 from the Outpatient Behavioral Health Clinic to the Northside Assertive Community Treatment team, following a move into supportive housing on 28 November.
First contact: the team's nurse visits K.A. at the new address on 2 December.
Before that: K.A.'s monthly injection was given on 14 November; the next is due on 12 December and must be given by the team, at home or at the team office.
The Regimen as Taken
Paliperidone palmitate 156 mg intramuscular injection every four weeks. Last given 14 November 2026, left deltoid. Last dose change: none since 2022.
Metformin 500 mg by mouth twice daily with meals, for antipsychotic-related weight gain and prediabetes. Last changed: started 2022.
Nicotine patch 14 mg daily, started 20 November, for tobacco cutting down from 10 cigarettes a day.
No other prescribed medicines. Takes no over-the-counter medicines.
All tablets are packed weekly by K.A.'s sister and delivered on Sundays; the sister will continue at the new address.
Live Concerns Only
Persisting voices most days, without command content since August; K.A. meets criteria for treatment-resistant schizophrenia, and clozapine has been recommended and accepted in principle.
Cannabis most evenings, reduced to "every other night" by K.A.'s report since October.
The move itself: the two previous relapses followed disruptions.
Low baseline neutrophil count (around 1,300 to 1,500 per microliter on five tests since 2020), which affects clozapine; hematology consultation requested.
Risk, With Dates
Suicide attempt by overdose: 2022, during relapse.
Command voices to walk into traffic: July 2025, before the third admission; none since August 2025.
Current: no suicidal intent; safety plan made 4 October, copies held by K.A. and K.A.'s sister; medicines held by the sister in weekly packs.
Open Items and Their Owners
Hematology consultation on the neutrophil count: requested 20 November; appointment 9 December. Owner: the team's psychiatric nurse practitioner, to receive the result and decide on clozapine.
Clozapine start: planned after the hematology result. Baseline tests needed: blood count with differential, electrocardiogram, troponin and C-reactive protein, metabolic panel, weight. Owner: the team's psychiatric nurse practitioner.
Cannabis and tobacco: brief intervention started; continue. Owner: the team's addiction specialist.
Injection on 12 December. Owner: the team nurse.
Housing: placement confirmed; tenancy support from the housing program. Owner: housing case manager, already in contact with the team.
Treatment resistance consensus criteria are summarized in the attached case analysis (Howes et al., 2017).
What Has Been Said
K.A. knows the clinic is handing over to the team, has met the team nurse once by video and has the team's number in the phone. K.A. knows clozapine is the plan, that it needs blood tests and that it will not start until the hematology appointment. K.A.'s sister knows the date of the move, the injection date and the team's number.
K.A. has not been told that clozapine is certain to work; K.A. was told that it is the best option for voices that have not responded to other medicines.
Why Clozapine Is Planned
The case analysis concluded that K.A. meets criteria for treatment-resistant schizophrenia. Clozapine is the antipsychotic with the strongest evidence in that situation (Kane et al., 1988). The team should expect K.A. to be hopeful about it and anxious about the blood tests.
Safety Plan
K.A.'s safety plan was made using a structured format (Stanley & Brown, 2012) and lists warning signs in K.A.'s words, the sister first among contacts and the 988 line for night-time. Please review it at the first home visit so K.A. knows the team has it.
What the Team Can Expect
K.A. is reliable with injections when reminded the day before, prefers text messages to calls and is most open in the morning. K.A.'s worst hours are late evening. The safety plan lists the sister first and the 988 line for night-time.
What Is Stable and Can Be Left Alone
Metformin and weight: stable on the current dose. Employment: stable; K.A. wants to keep the grocery job through the move. Contact with the sister: stable and supportive. These should not be changed during the first months with the team, while the move and the clozapine start bring enough change on their own. If the team sees signs of relapse during the move, the first step is to check whether the injection was given on time.
Physical Health Monitoring Due
Weight, waist, fasting glucose and lipids last checked in September; next due in December, before clozapine starts, and then at least every three months on clozapine. Owner: the team nurse.
Contact for Questions
The outpatient clinic's attending nurse practitioner remains available by phone until 31 December for questions about this transfer.
References
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., Castle, D. J., Citrome, L., Daskalakis, Z. J., Davidson, M., Drake, R. J., Dursun, S., Ebdrup, B. H., Elkis, H., Falkai, P., ... Correll, C. U. (2017). Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. American Journal of Psychiatry, 174(3), 216-229. https://doi.org/10.1176/appi.ajp.2016.16050503
Kane, J., Honigfeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45(9), 789-796. https://doi.org/10.1001/archpsyc.1988.01800330013001
Stanley, B., & Brown, G. K. (2012). Safety planning intervention: A brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice, 19(2), 256-264. https://doi.org/10.1016/j.cbpra.2011.01.001
The Chamberlain NR 607 Week 6 instructions
The Week 6 summary reads as instructions more than history. The first lines say what happens next: when the person is seen again, by whom and what must be done before that. Give the current regimen exactly as taken, with the date of the last change. Keep what is unstable now apart from what has settled. Date every risk event. List open tasks with an owner each and pending results with someone chasing them. Say what the person has been told. Most rubrics mark down a summary that copies the whole chart, a regimen without doses or last-changed dates, open tasks with no owner and risk without dates.
How this NR 607 Week 6 example is built
The sample's first section gives the transfer date, the team nurse's first visit and the next injection due on 12 December. The regimen lists the injection, metformin and a nicotine patch, each with dose, last given or started and who packs the tablets. Live concerns are limited to persisting voices, cannabis, the move and the low neutrophil count. Risk events carry dates. Open items, including the hematology appointment, clozapine baseline tests and the next injection, each have an owner. Sections cover why clozapine is planned, the safety plan, what the team can expect, what is stable, physical health monitoring due and a contact for questions.
NR 607 Week 6 rubric: what full points look like
The heaviest loss is a summary that copies the whole chart and buries the two lines the receiving clinician needed; this one opens with what happens first. A regimen without doses or last-changed dates forces reconstruction, while each medicine here has both. Open tasks with no owner lose a row, and every item here is assigned. Risk without dates loses marks, and each event is dated. Recording what the person and family have been told earns the communication criterion, and pointing the team to the safety plan makes sure it travels. Naming what is stable and should be left alone protects the person from too many changes at once. Listing physical health monitoring due, with an owner, prevents it from being lost in the handover.
Common NR 607 Week 6 mistakes, and how to avoid them
Weak NR 607 Week 6 summaries attach the full chart and expect the receiving team to find what matters. Others list prescribed medicines rather than what is actually taken. Many give open tasks without saying who will do them. Risk is often summarized without dates. Few say what the patient has been told. Start with what happens first and when, list the regimen as taken with last-changed dates, keep only live concerns, date risk events and give every open item an owner. If your transition differs, list the next steps and medicines, and a handover in this form can be drafted. Say who owns each open item.
Get a NR 607 Week 6 example written to your instructions
Send the Week 6 prompt from your classroom, plus the summary template if your section publishes one, and a custom example is written to that receiving service and returned inside 24 to 48 hours. The first one is free. Tell us who the summary is addressed to and it will be written to them.
More NR 607 papers and PMHNP samples
- NR 607 Week 1: Missing Fact in the Record Post
- NR 607 Week 2: Longitudinal Case Write-Up
- NR 607 Week 3: Safety Plan Write-Up
- NR 607 Week 4: Care Coordination Note
- NR 607 Week 5: Treatment Resistance Case Analysis
- NR 607 Week 7: Consultation Write-up
- NR 607 Week 8: Synthesis Case Paper
- NR 606 Week 6: Augmentation Rationale
- NR 546 Week 6: Adverse Effect Brief
- NR 605 Week 6: Follow-Up Note
- NR 547 Week 6: Lifespan Variation Write-Up
NR 607 Week 6 questions, answered
How long should a handover summary be?
Shorter than students expect. One page a colleague reads before the appointment beats four pages skimmed in a corridor. The fuller history belongs in the record this summary points to. Assignments here are usually marked on selection rather than on coverage, so what has been left out is doing as much work as what stayed in.
Is this the same as the Week 2 write-up?
They overlap and they are marked differently. The longer write-up compresses a history for the record. This one is addressed to a named role starting on a date, so it carries actions, owners and deadlines. One is an account of what happened, the other an instruction for what happens next, and drafts blurring them lose points in both directions.
What if information is missing?
Say so, plainly, and say who is finding out. A gap named is manageable. A gap hidden behind confident prose is how something gets missed. Writing that a result is outstanding, that a previous record has been requested, or that a date could not be confirmed counts as good handover rather than as an admission of an unfinished assignment.
Where can I find a free NR 607 Week 6 sample paper?
The full transition of care summary to an assertive community treatment team is published on this page.
Who owns the clozapine decision in the NR 607 Week 6 summary?
The receiving team's psychiatric nurse practitioner, who will receive the hematology result and order the baseline tests before starting.